Inhibitory effect of recombinant IL-25 on the development of dextran sulfate sodium-induced experimental colitis in mice

Cellular and Molecular Immunology

Volumn 5, Issue 6, 2008, Pages 425-431

  Mchenga, S S Salum ^a   Wang, Danan ^a   Li, Cheng ^a   Shan, Fengping ^a   Lu, Changlong ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

colitis; dextran sulfate sodium; disease activity index; IL 25

Indexed keywords

DEXTRAN SULFATE; INTERLEUKIN 17; INTERLEUKIN 23; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL; ARTICLE; C57BL MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COLITIS; DISEASE COURSE; DRUG EFFECT; FEMALE; FLOW CYTOMETRY; IMMUNOLOGY; KAPLAN MEIER METHOD; METABOLISM; MOUSE; PATHOLOGY;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COLITIS; DEXTRAN SULFATE; DISEASE PROGRESSION; FEMALE; FLOW CYTOMETRY; INTERLEUKIN-17; INTERLEUKIN-23; KAPLAN-MEIERS ESTIMATE; MICE; MICE, INBRED C57BL; RECOMBINANT PROTEINS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 62449296656     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2008.53     Document Type: Article

References (37)

1. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347:417-429. (Pubitemid 34851835)
2. Carpenter HA, Talley NJ. The importance of clinicopathological correlation in the diagnosis of inflammatory conditions of the colon: histological patterns with clinical implication. Am J Gastroenterol. 2000;95:878-896. (Pubitemid 30196720)
3. Hanauer SB. Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities. Inflamm Bowel Dis. 2006;12 Suppl 1: S3-9. (Pubitemid 43068428)
4. Byryne FR, Viney JL. Mouse model of inflammatory bowel disease. Curr Opin Drug Disc Devel. 2006;9:207-217.
5. Egger B, Bajaj-Elliot M, MacDonald TT, Inglin R, Eysselein VE, Büchler MW. Characterization of acute murine dextran sodium sulphate colitis: cytokine profile and dose dependency. Digestion. 2000;62:240-248.
6. Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity. 2004;21:467-476. (Pubitemid 39370503)
7. Kawaguchi M, Adachi M, Oda N, Kokubu F, Huang SK. IL-17 cytokine family. J Allergy Clin Immunol. 2004;114:1265-1273; quiz 1274. (Pubitemid 39585195)
8. Fort MM, Cheung J, Yen D, et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity. 2001;15:985-995. (Pubitemid 34075378)
9. Ikeda K, Nakajima H, Suzuki K, et al. Mast cells produce interleukin-25 upon FcεRI-mediated activation. Blood. 2003;101:3594-3596. (Pubitemid 36857947)
10. Lee J, Ho WH, Maruoka M, et al. IL17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL17Rh1. J Biol Chem. 2001;276:1660-1664. (Pubitemid 32096603)
11. Fallon PG, Ballantyne SJ, Mangan NE, et al. Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J Exp Med. 2006;203:1105-1116.
12. Owang AM, Zaph C, Willson EH, et al. Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract. J Exp Med. 2006;203:843-849.
13. Cooper HS, Murthy SN, Shah RS, Sedergran DJ. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest. 1993;69:238-249.
14. Melgar S, Karlsson A, Michaelsson E. Acute colitis induced by dextran sulfate sodium progress to chronicity in C57BL/6 but not in BALB/c mice: correlation between symptoms and inflammation. Am J Physiol Gastrointest Liver Physiol. 2005;288: G1328-1338. (Pubitemid 40741088)
15. Madden KB, Whitman L, Sullivan, et al. Role of STAT6 and mast cells in IL-4-and IL-13-induced alteration in murine intestinal epithelium cell function. J Immunol. 2002;169:4417-4422. (Pubitemid 35178216)
16. Zhao AC, McDermott J, Urban JF Jr, et al. Dependence of IL-4, IL-13, and nematode-induced alterations in murine small intestinal smooth muscle contractility on Stat6 and enteric nerves. J Immunol. 2003;171:948-954. (Pubitemid 36871409)
17. Neurath MF, Fuss I, Schumann G, et al. Cytokine gene transcription by NF-κB family members in patients with inflammatory bowel diseases. Ann NY Acad Sci. 1998;859:149-159. (Pubitemid 29021014)
18. Erdman S, Fox JG, Dangler CA, Feldman D, Horwitz BH. Typhlocolitis on NF-κB-deficient mice. J Immunol. 2001;166:1443-1447.
19. Artis D, Shapira S, Mason N, et al. Differential requirement for NF-κB family members in control of helminth infection and intestinal inflammation. J Immunol. 2002;169:4481-4487. (Pubitemid 35178225)
20. Kleinschek MA, Owyang AM, Joyce-Shaikh B, et al. IL-25 regulates Th17 in autoimmune inflammation. J Exp Med. 2007;204:161-170. (Pubitemid 46148766)
21. Fichtner-Feigl S, Fuss IJ, Young CA, et al. Introduction of IL-13 triggers TGF-β1-dependent tissue fibrosis in 2, 4, 5,-trinitrobenzene sulfonic colitis. J Immunol. 2007;178:5859-5870. (Pubitemid 46674383)
22. Wahl SM. Transforming growth factor β: the good, the bad, and the ugly. J Exp Med. 1994;180:1587-1590. (Pubitemid 24328550)
23. Beck PL, Podolsky DK. Growth factors in inflammatory bowel disease. Inflamm Bowel Dis. 1999;5:44-60.
24. Fuss IJ, Boirivant M, Lacy B, Strober W. The interrelated roles of TGF-β and IL-10 in the regulation of experimental colitis. J Immunol. 2002;168:900-908. (Pubitemid 34049594)
25. Kitani A, Fuss IJ, Nakamura K, Schwartz OM, Usui T, Strober W. Treatment of experimental (Trinitrobenzene sulfonic acid) colitis by intranasal administration of transforming growth factor (TGF)-β1 plasmid: TGF-β1-mediated suppression of T helper cell type 1 response occurs by interleukin (IL)-10 induction and IL-12 receptor β2 chain downregulation. J Exp Med. 2000;192:41-52. (Pubitemid 30470805)
26. Kullberg MC, Jan Kovic D, Feng CJ, et al. IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J Exp Med. 2006;203:2485-2494. (Pubitemid 44664618)
27. Hue S, Ahern P, Buonocore S, et al. Interleukin-23 drives innate and T cell-mediated intestinal inflammation. J Exp Med. 2006;203:2473-2483. (Pubitemid 44664617)
28. H17 lineage. Nature. 2006;441:231-234.
29. Kinugasa T, Sakaguchi T, Gu X, Reinecker HC. Claudins regulate the intestinal barrier in response to immune mediators. Gastroenterology. 2000;118:1001-1011. (Pubitemid 30346975)
30. Ogawa A, Andoh A, Araki Y, Bamba T, Fujiyama Y. Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin Immunol. 2004;110:55-62. (Pubitemid 38177420)
31. Murphy CA, Langrish CL, Chen Y, et al. Divergent pro-and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med. 2003;198:1951-1957. (Pubitemid 38032126)
32. Vanden Eijnden S, Goriely S, De Wit D, Willems F, Goldman M. IL-23 up-regulates IL-10 and induces IL-17 synthesis by polyclonally activated naïve T cells in human. Eur J Immunol. 2005;35:469-475. (Pubitemid 40331324)
33. Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B. TGFβ in context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity. 2006;24:179-189. (Pubitemid 43214587)
34. Lockhart E, Green AM, Flynn JL. IL-17 production is dominated by γδT cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J Immunol. 2006;177:4662-4669. (Pubitemid 44469799)
35. Yeung MM, Melgar S, Baranov V, et al. Characterisation of mucosal lymphoid aggregates in ulcerative colitis: immune cell phenotype and TCR-γδ expression. Gut. 2000;47:215-227. (Pubitemid 30489765)
36. Kuhl AA, Pawloski NN, Grollich K, Loddenkemper C, Zeitz M, Hoffmann JC. Aggravation of intestinal inflammation by depletion/deficiency of γδT cells indifferent types of IBD animal models. J Leukoc Biol. 2007;81:168-175. (Pubitemid 46021266)
37. Stockinger B, Veldhoen M, Martin B. Th17 T cells: Linking innate and adoptive immunity. Semin Immunol. 2007;19:353-361. (Pubitemid 351274048)